切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 133 -137. doi: 10.3877/cma.j.issn.2095-3232.2018.02.012

所属专题: 文献

临床研究

髂动脉搭桥Meso-Rex术治疗原发性门静脉海绵样变性
沙地克·阿帕尔1, 吐尔洪江·吐逊1, 姚刚1, 江多斯·帕依孜吾拉1, 张皓1, 赵晋明1, 李涛1,()   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院消化血管外科中心肝(移植)·腹腔镜外科
  • 收稿日期:2017-12-29 出版日期:2018-04-10
  • 通信作者: 李涛
  • 基金资助:
    国家自然科学基金(81560329)

Meso-Rex bypass using iliac arterial for primary cavernous transformation of portal vein

Apaer Shadike1, Tuxun Tuerhongjiang1, Gang Yao1, Payiziwula Jiangduosi1, Hao Zhang1, Jinming Zhao1, Tao Li1,()   

  1. 1. Department of Liver Transplantation & Laparoscopic Surgery, Digestive & Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2017-12-29 Published:2018-04-10
  • Corresponding author: Tao Li
  • About author:
    Corresponding author: Li Tao, Email:
引用本文:

沙地克·阿帕尔, 吐尔洪江·吐逊, 姚刚, 江多斯·帕依孜吾拉, 张皓, 赵晋明, 李涛. 髂动脉搭桥Meso-Rex术治疗原发性门静脉海绵样变性[J]. 中华肝脏外科手术学电子杂志, 2018, 07(02): 133-137.

Apaer Shadike, Tuxun Tuerhongjiang, Gang Yao, Payiziwula Jiangduosi, Hao Zhang, Jinming Zhao, Tao Li. Meso-Rex bypass using iliac arterial for primary cavernous transformation of portal vein[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(02): 133-137.

目的

探讨采用髂动脉搭桥肠系膜上静脉-肝内门静脉左支分流术(Meso-Rex)治疗原发性门静脉海绵样变性(CTPV)的可行性。

方法

患者女,40岁,因"上腹部隐痛不适4周"入院。腹部CT血管造影示CTPV,食管下端、胃底静脉曲张,脾大。入院诊断:原发性CTPV。应用心脏死亡器官捐献来源的髂动脉在肠系膜上静脉和肝内门静脉左支间搭桥行Meso-Rex术。术后采用肝素钠抗凝治疗,超声检查随访。患者签署知情同意书,符合医学伦理学规定。

结果

患者手术顺利,术后复查搭桥血管血流通畅,未出现并发症。患者随访3个月,搭桥血管无血栓形成。

结论

Meso-Rex术是CTPV的治愈性术式,其临床疗效确切。髂动脉作为分流血管是安全可行的。术后积极抗凝治疗,预防血栓形成是手术成功的关键。

Objective

To explore the feasibility of superior mesenteric vein-left portal vein bypass (Meso-Rex) using iliac arterial in the treatment of primary cavernous transformation of portal vein (CTPV).

Methods

The patient, female, 40 years old, was hospitalized due to dull pain in the upper abdomen for4 weeks. Abdominal CT angiography showed CTPV, varicosity in the lower esophagus and fundus of stomach, and splenauxe. The admitting diagnosis was primary CTPV. Meso-Rex was performed using iliac artery from donation after cardiac death bridging between superior mesenteric vein and left intrahepatic portal vein. The patient was given heparin for anticoagulation therapy and was followed up by ultrasound after the operation. The informed consent of this patient were obtained and the local ethical committee approval was received.

Results

The operation was performed successfully. The blood flow of bypass vessel was good after operation, and no complication was observed. During 3 months follow-up, no thrombosis in the bypass blood vessel was observed.

Conclusion

Meso-Rex is a curative operation for CTPV, and has definite clinical effect. Iliac artery is safe and feasible when used as a shunt vessel. Giving active anticoagulant therapy to prevent thrombosis after operation is the key to success.

图1 门静脉海绵样变性患者腹部CT血管造影图像
图2 门静脉海绵样变性患者Meso-Rex术中图像
图3 门静脉海绵样变性患者Meso-Rex术后彩超检查图像
[1]
许斌.小儿门静脉海绵样变性的外科治疗现状[J].现代医药卫生,2013,29(13):1991-1993.
[2]
Zhang WG, Li Z, Ding PX, et al. Endovascular treatment ofan unusual primary arterioportal fistula complicated by cavernous transformation of the portal vein caused by portal thrombosis[J]. Ann Vasc Surg, 2014, 28(2):491.
[3]
董家鸿.精准外科时代门静脉高压症的外科治疗策略[J].中华消化外科杂志,2013,12(11):811-813.
[4]
Kuy S, Dua A, Rieland J, et al. Cavernous transformation of the portal vein[J]. J Vasc Surg, 2016, 63(2):529.
[5]
de Ville de Goyet J, Lo Zupone C, Grimaldi C, et al. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives[J]. Pediatr Transplant, 2013, 17(1):19-26.
[6]
Chaves IJ, Rigsby CK, Schoeneman SE, et al. Pre-and postoperative imaging and interventions for the meso-Rex bypass in children and young adults[J]. Pediatr Radiol, 2012, 42(2):220-232.
[7]
di Francesco F, Grimaldi C, de Ville de Goyet J. Meso-Rex bypass--a procedure to cure prehepatic portal hypertension:the insight and the inside[J]. J Am Coll Surg, 2014, 218(2):e23-36.
[8]
吕金利,侯振宇,李雪平.门静脉海绵样变性的诊治分析[J].局解手术学杂志,2013,22(2):192-193.
[9]
董家鸿,纪旭.门静脉海绵样变性的外科治疗策略[J].中华消化杂志,2014,34(1):10-12.
[10]
Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications[J]. World J Gastroenterol, 2014, 20(45):16996-17010.
[11]
Superina RA, de Ville de Goyet J. Preemptive Meso-Rex bypass for children with idiopathic prehepatic portal hypertension:trick or treat?[J]. J Pediatr Gastroenterol Nutr, 2014, 58(4):e41.
[12]
El-Shabrawi MH, Kamal NM. Medical management of chronic liver diseases (CLD) in children (partⅡ): focus on the complications of CLD, and CLD that require special considerations[J]. Paediatr Drugs, 2011, 13(6):371-383.
[13]
Sebastiani S, Martens T, Randon C, et al. Meso-Rex shunt using deep femoral vein conduit:first report[J]. Acta Chir Belg, 2013, 113(5):375-377.
[14]
Lautz TB, Keys LA, Melvin JC, et al. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children[J]. J Am Coll Surg, 2013, 216(1):83-89.
[15]
Bhat R, Lautz TB, Superina RA, et al. Perioperative strategies and thrombophilia in children with extrahepatic portal vein obstruction undergoing the meso-Rex bypass[J]. J Gastrointest Surg, 2013, 17(5):949-955.
[16]
管清海,陈强谱,张长习.血管移植物在腹部静脉修复重建中的应用[J].中国现代普通外科进展,2011,14(4):299-301.
[17]
Guérin F, Bidault V, Gonzales E, et al. Meso-Rex bypass for extrahepatic portal vein obstruction in children[J]. Br J Surg, 2013, 100(12):1606-1613.
[18]
Facciuto ME, Rodriguez-Davalos MI, Singh MK, et al. Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction[J]. Surgery, 2009, 145(4):406-410.
[19]
Ha TY, Kim KM, Ko GY, et al. Variant meso-Rex bypass with transposition of abdominal autogenous vein for the management of idiopathic extrahepatic portal vein obstruction:a retrospective observational study[J]. BMC Surg, 2015(15):116.
[20]
Wei Z, Rui SG, Yuan Z, et al. Partial splenectomy and use of splenic vein as an autograft for meso-Rex bypass:a clinical observational study[J]. Med Sci Monit, 2014(20):2235-2242.
[1] 黄钰清, 武杜杜, 潘菲, 王俊康, 钟兆明, 黎檀实, 吕发勤. 掌上超声在枪弹伤致髂动脉破裂大出血建模中的应用研究[J]. 中华医学超声杂志(电子版), 2022, 19(10): 1112-1117.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 耿志达, 俞星新, 刘雨, 梁英健. 脾切除术后门静脉血栓形成及其机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(01): 110-113.
[4] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[5] 赫嵘, 贾哲, 张珂, 李代京, 张萌, 蒋力. 基于PSM分析腹腔镜肝切除联合Hassab术治疗合并门静脉高压症肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 376-383.
[6] 许语阳, 吕云福, 王葆春. 乙肝后肝硬化门静脉高压症脾肿大外科治疗进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 469-473.
[7] 杨林青, 任松, 纪泛扑, 张健, 蒋安, 张丽, 安鹏, 王林, 李宗芳. 揿针疗法对门静脉高压症脾切除断流术后胃肠功能的调节作用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 322-326.
[8] 刘琦, 史冀华, 张水军. 活体肝移植术后的小肝综合征[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 645-648.
[9] 汤朝晖, 张建生, 陈其龙, 邓薇薇, 王劲. TIPS术后支架评估中的光谱CT最佳单能级图像研究[J]. 中华肝脏外科手术学电子杂志, 2022, 11(05): 463-468.
[10] 张长坤, 李煜子, 张龙辉, 王东. 胰源性门静脉高压症诊治进展[J]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 13-16.
[11] 李志伟, 齐瑞兆, 赵新, 常伟华, 常正尧, 张鹰, 王胜智, 梁峰. 门静脉高压症脾切除切口微创化发展[J]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 17-20.
[12] 王栋, 阴继凯, 董瑞, 鲁建国. 门静脉高压症微创手术全程管理模式单中心经验[J]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 21-26.
[13] 张春, 林婷, 张靖垚, 刘司南, 苗润晨, 王铮, 刘昌. 急性胰腺炎合并区域性门静脉高压症诊治分析[J]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 48-53.
[14] 陈世赓, 梁明军, 关蛟, 周尊强, 周光文. 三种结扎方式在贲门周围血管离断术中应用的比较[J]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 599-603.
[15] 胡竞雄, 周静, 黄茜, 马瑞颖, 彭文广, 钟跃思. 肝胆影像学指标对乙肝后肝硬化门静脉高压症患者肝功能预测价值[J]. 中华肝脏外科手术学电子杂志, 2021, 10(05): 493-497.
阅读次数
全文


摘要